in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – January 17
6:20 AM MST | January 17, 2012 | Deepti Ramesh
GENERIC DRUG USER FEE PROGRAM GOES TO CONGRESS The U.S. Food and Drug Administration (FDA) says it has completed its recommendations for the proposed generic drug user fee program (GDUFA). The recommendations were transmitted by the Department of Health and Human Services to Congress on January 13. GDUFA will require FDA to improve significantly its regulatory activities for the benefit of generic drug providers and U.S. generic drug consumers. The global generics industry, in exchange, will provide FDA with $299 million/year in user fees over the next five...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee